ESC 365 - Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy

ESC2024 Premium Access

Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy

Session: Familial hypercholesterolaemia and cardiovascular risk

Topic: Lipids

Speaker: Doctor M. Deniz (Istanbul, TR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Muhammed Furkan Deniz

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Türkiye)

1 follower

7 more presentations in this session

Impact of addressing modifiable risk factors on the 10-year risk of cardiovascular disease in individuals with familial hypercholesterolemia: a causal analysis utilising UK biobank

Speaker: Mr C. Stevens (London, GB)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks

Speaker: Doctor H. Tada (Kanazawa, JP)

The effectiveness and barrier of reverse cascade screening for paediatric familial hypercholesterolaemia

Speaker: Doctor R. Tani (Kagawa, JP)

Lipoprotein(a) levels and cholesterol efflux capacity: inverse association and impact on atherosclerosis in familial hypercholesterolemia patients on lipid-lowering therapy

Speaker: Doctor M. Ogura (Urayasu, JP)

Impact of changes of Achilles tendon thickening on cardiovascular events among patients with familial hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Access the full session

Familial hypercholesterolaemia and cardiovascular risk

Speakers: Doctor M. Deniz, Mr C. Stevens, Doctor H. Tada, Doctor R. Tani, Doctor M. Ogura...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources